HALO vs PeraMobile and PeraWatch
AI Verdict
Choose HALO if…
Choose HALO if your primary need is rapid, AI-powered detection and triage of acute stroke patients, specifically for large vessel occlusions and intracerebral hemorrhage. This tool is ideal for emergency settings requiring immediate analysis of CT angiograms and automated notifications to specialists to expedite critical stroke interventions.
View HALO →Choose PeraMobile and PeraWatch if…
Choose PeraMobile and PeraWatch if your organization requires a comprehensive, system-wide solution for real-time patient acuity scoring and predictive analytics to identify general patient deterioration across various conditions. This platform is best suited for proactive patient management, enabling earlier intervention through EHR integration, mobile access, and configurable alerts for at-risk patients.
View PeraMobile and PeraWatch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HALO | PeraMobile and PeraWatch |
|---|---|---|
| Pricing | Not disclosed | Contact for pricing |
| Deployment | Cloud-based (Google Cloud Platform) | Software-only, integrated with EHRs, web-based access, mobile application, on user-provided hardware. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
PeraMobile and PeraWatchPeraMobile and PeraWatch offer a broader and more flexible user experience, including a mobile application for on-the-go clinicians and web-based access with visual dashboards for system-wide surveillance. While HALO provides remote review via a DICOM web viewer and smartphone access for stroke specialists, PeraHealth's solutions cater to a wider range of clinical activities and roles with diverse access points.
Clinical Value
HALOHALO provides AI-powered, rapid detection of large vessel occlusions (LVO) and intracerebral hemorrhage (ICH) in acute stroke patients, with a demonstrated sensitivity of 91.1% and specificity of 87.0% for LVO detection and a median notification time of 4 minutes 31 seconds. This direct and time-critical diagnostic support for acute stroke has been shown to reduce time to treatment and patient disability. PeraHealth's Rothman Index also offers significant clinical value by predicting patient deterioration and has been associated with a 30% reduction in hospital mortality.
Pricing & Value
TieBoth HALO and PeraMobile/PeraWatch have undisclosed pricing, requiring direct contact with the vendor for information. Without transparent pricing details for either solution, it is not possible to conduct a head-to-head comparison of their cost-effectiveness or overall value.
Enterprise Readiness
PeraMobile and PeraWatchPeraMobile and PeraWatch demonstrate strong enterprise readiness through their integration with major EHR vendors, flexible deployment options including software-only and on user-provided hardware, and web/mobile access [cite: JSON, 4, 8]. Furthermore, PeraHealth's acquisition by Spacelabs Healthcare, a larger medical device company, provides additional credibility for enterprise deployment and long-term support [cite: JSON, 28]. HALO's cloud-based deployment on Google Cloud Platform and DICOM/PACS integration are also robust, but PeraHealth's broader integration strategy and corporate backing give it an edge [cite: JSON, 26].
Innovation
HALOHALO leverages advanced AI, specifically deep learning, for rapid and precise image analysis in acute stroke, including LVO/ICH detection, volume quantification, vessel segmentation, and thrombus detection [cite: JSON, 9, 19]. This application of AI directly addresses a critical, time-sensitive diagnostic need in a highly specialized manner. While PeraHealth's Rothman Index is an innovative predictive model for patient deterioration, HALO's specific AI for image interpretation represents a more cutting-edge application of AI technology in healthcare diagnostics.
Support & Docs
TieFor HALO by Nico.Lab, there is an explicit mention of 'limited publicly available technical documentation'. For PeraMobile and PeraWatch, the provided structured facts and web searches did not yield specific details regarding customer support channels or the availability and quality of documentation. Due to the lack of comprehensive and comparable information for both tools, a definitive winner cannot be determined in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HALO | PeraMobile and PeraWatch |
|---|---|---|
| Name | HALO | PeraMobile and PeraWatch |
| Company | Nico.Lab B.V. | PeraHealth (acquired by Spacelabs Healthcare) |
| Primary Clinical Focus | Rapid detection of large vessel occlusions and intracerebral hemorrhage in acute stroke patients, providing timely notifications to medical specialists. | Identify at-risk patients sooner for earlier intervention, improve quality, and reduce costs. |
| Core Analytical Function | AI-powered Large Vessel Occlusion (LVO) detection; Intracerebral Hemorrhage (ICH) detection and volume quantification. | Real-time patient acuity scoring (Rothman Index); Predictive analytics for patient deterioration. |
| Notification Capabilities | Automated notifications to medical specialists. | Configurable warning states and push notifications. |
Videos
Demos, reviews, and walkthroughs featuring HALO and PeraMobile and PeraWatch.